clinical trial · NCT07181538
Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers
HealthyJLP-2302JP-1366
brief summary
This study aims to evaluate the pharmacokinetics and the safety after administration of "JLP-2302" and "JP-1366" in healthy volunteers.
started
Feb 4, 2025
primary completion
Feb 20, 2025
completion
Mar 5, 2025
last updated
Sep 18, 2025
official title
Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "JLP-2302" and "JP-1366" in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol